Erin Miller, Marketing Director
FOR IMMEDIATE RELEASE
22nd Study published on the probiotic GanedenBC30
Study demonstrations pasta as an effective delivery system for patented probiotic
CLEVELAND, OH (November 5, 2015) - Ganeden, the recognized innovator in probiotics, is excited to announce the 22nd study on the patented probiotic GanedenBC30 is now published in the Journal of Cereal Science. Research confirms GanedenBC30 survives in efficacious amounts thru the manufacturing and preparation of pasta.
The study, conducted by the University of Verona, developed pasta formulated with GanedenBC30 to analyze and highlight the health potential of a functional pasta. Results of the research, completed by using standard USP enumeration protocols, illustrated GanedenBC30 left the characteristics of the pasta unaffected and displayed survival in efficacious levels at both five and seven minute cook times.
“This study is exciting, as it shows the distinctive formulation capabilities of GanedenBC30 in an additional product category that would be impossible for traditional probiotics,” said Mike Bush, Senior VP of Ganeden. “This research not only continues to build on our library of science supporting GanedenBC30, but as a science driven company we are honored that the Italian Ministry of Health continues to choose GanedenBC30 for their studies; a collaboration which dates back to 2007.”
Click here to read the complete study.
GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden’s patented probiotic ingredient that can be found in more than 150 leading food, beverage, sports nutrition and companion animal products around the world. Unlike most other probiotic strains, GanedenBC30 is a spore-former which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by over 20 published studies showing safety, digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage or companion animal product that is baked, boiled, frozen or squeezed…. including all hot or refrigerated beverages! For more information, please visit GanedenBC30.com.
Ganeden is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, non-GMO, highly stable probiotic ingredient. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden and licensing opportunities visit GanedenProbiotics.com.